Knoa Pharma: Osteoarthritis trials
The registry lists 13 Osteoarthritis studies with Knoa Pharma as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 2 3Phase 3 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the KneeCompletedNCT03028870Phase 2Results posted
- Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension PhaseCompletedNCT01141283Phase 3Results posted
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension PhaseTerminatedNCT01135524Phase 3Results posted
- Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of KneeCompletedNCT00531427Phase 3Results posted
- Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.TerminatedNCT00320801Phase 3Results posted
- Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.TerminatedNCT00315458Phase 3Results posted
- Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or KneeCompletedNCT00313846Phase 3Results posted
- Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA PainCompletedNCT00312572Phase 3Results posted
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis PainTerminatedNCT00312221Phase 3Results posted
- A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the KneeTerminatedNCT02847702Phase 2
- Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the KneeCompletedNCT01688934Phase 2
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.CompletedNCT00315848Phase 3
- Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.CompletedNCT00314652Phase 3